HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheryl Longman Selected Research

Terpenes (Terpenoids)

1/2013ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheryl Longman Research Topics

Disease

6Muscular Dystrophies (Muscular Dystrophy)
06/2013 - 11/2003
4Muscular Diseases (Myopathy)
11/2022 - 06/2012
3Walker-Warburg Syndrome
01/2013 - 11/2003
3Intellectual Disability (Idiocy)
01/2008 - 11/2003
2Muscle Weakness
01/2021 - 02/2015
2Arthrogryposis
12/2019 - 07/2014
2Left Ventricular Dysfunction
01/2017 - 01/2017
2Myotonic Dystrophy (Dystrophia Myotonica)
01/2017 - 01/2017
2Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2008 - 12/2003
1Muscular Atrophy (Muscle Atrophy)
11/2022
1Myotonia
01/2021
1Sideroblastic Anemia
01/2017
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Cardiomyopathies (Cardiomyopathy)
01/2016
1Spinal muscular atrophy with respiratory distress 1
02/2015
1Nemaline Myopathies (Nemaline Myopathy)
07/2014
1Multiple pterygium syndrome
07/2014
1Cap Myopathy
07/2014
1Congenital Structural Myopathies (Centronuclear Myopathy)
07/2014
1Spastic Ataxia
05/2014
1Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
05/2014
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
02/2013
1Neuromuscular Diseases (Neuromuscular Disease)
02/2013
1Mitochondrial Diseases (Mitochondrial Disease)
09/2012
1Channelopathies
02/2010
1Type IIC Hereditary Motor And Sensory Neuropathy
02/2010
1Polymicrogyria
11/2008
1Cysts
11/2008
1Myopia
01/2008
1Eye Abnormalities (Eye Abnormality)
11/2003

Drug/Important Bio-Agent (IBA)

5Dystroglycans (Dystroglycan)IBA
01/2013 - 11/2003
4Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2003
3protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA
11/2008 - 11/2003
2Troponin IIBA
01/2017 - 01/2017
2DystrophinIBA
01/2016 - 02/2013
2Mitochondrial DNA (mtDNA)IBA
05/2014 - 09/2012
2EnzymesIBA
01/2008 - 03/2005
2GlycosyltransferasesIBA
03/2005 - 11/2003
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2022
1ConnectinIBA
01/2021
1TroponinIBA
01/2017
1Lactic Acid (Lactate)FDA LinkGeneric
01/2017
1Immunoglobulins (Immunoglobulin)IBA
02/2015
1Carrier Proteins (Binding Protein)IBA
02/2015
1TropomyosinIBA
07/2014
1Protein Isoforms (Isoforms)IBA
07/2014
1DesminIBA
06/2013
1Terpenes (Terpenoids)IBA
01/2013
1oligomycin sensitivity-conferring protein (complex V)IBA
09/2012
1Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA
09/2012
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
06/2012
1AnkyrinsIBA
02/2010

Therapy/Procedure

1Continuous Positive Airway Pressure
11/2022
1Cataract Extraction
01/2021
1Artificial Respiration (Mechanical Ventilation)
02/2015
1Ligation
05/2014